These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 21912600)

  • 1. KIR and HLA-C interactions promote differential dendritic cell maturation and is a major determinant of graft failure following kidney transplantation.
    Hanvesakul R; Kubal C; Moore J; Neil D; Cook M; Ball S; Briggs D; Moss P; Cockwell P
    PLoS One; 2011; 6(8):e23631. PubMed ID: 21912600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human Leukocyte Antigen-C Genotype and Killer Immunoglobulin-like Receptor-Ligand Matching in Korean Living Donor Liver Transplantation.
    Lee H; Park KH; Park HS; Ryu JH; Lim J; Kim Y; Na GH; Kim DG; Oh EJ
    Ann Lab Med; 2017 Jan; 37(1):45-52. PubMed ID: 27834065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of Killer Immunoglobulin-like Receptor (KIR) and HLA Genotypes to Predict the Occurrence of Acute Allograft Rejection after Kidney Transplantation.
    Jafari D; Nafar M; Yekaninejad MS; Abdolvahabi R; Lesan Pezeshki M; Razaghi E; Amirzargar AA
    Iran J Allergy Asthma Immunol; 2017 Jun; 16(3):245-255. PubMed ID: 28732438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KIR gene mismatching and KIR/C ligands in liver transplantation: consequences for short-term liver allograft injury.
    Legaz I; López-Álvarez MR; Campillo JA; Moya-Quiles MR; Bolarín JM; de la Peña J; Salgado G; Gimeno L; García-Alonso AM; Muro M; Miras M; Alonso C; Álvarez-López MR; Minguela A
    Transplantation; 2013 Apr; 95(8):1037-44. PubMed ID: 23478359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KIR and their HLA Class I ligands: Two more pieces towards completing the puzzle of chronic rejection and graft loss in kidney transplantation.
    Littera R; Piredda G; Argiolas D; Lai S; Congeddu E; Ragatzu P; Melis M; Carta E; Michittu MB; Valentini D; Cappai L; Porcella R; Alba F; Serra M; Loi V; Maddi R; Orrù S; La Nasa G; Caocci G; Cusano R; Arras M; Frongia M; Pani A; Carcassi C
    PLoS One; 2017; 12(7):e0180831. PubMed ID: 28686681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Donor HLA-C genotype has a profound impact on the clinical outcome following liver transplantation.
    Hanvesakul R; Spencer N; Cook M; Gunson B; Hathaway M; Brown R; Nightingale P; Cockwell P; Hubscher SG; Adams DH; Moss P; Briggs D
    Am J Transplant; 2008 Sep; 8(9):1931-41. PubMed ID: 18671674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NK cell tolerance of self-specific activating receptor KIR2DS1 in individuals with cognate HLA-C2 ligand.
    Pittari G; Liu XR; Selvakumar A; Zhao Z; Merino E; Huse M; Chewning JH; Hsu KC; Dupont B
    J Immunol; 2013 May; 190(9):4650-60. PubMed ID: 23554313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KIR2DS1-dependent acquisition of CCR7 and migratory properties by human NK cells interacting with allogeneic HLA-C2+ DCs or T-cell blasts.
    Marcenaro E; Pesce S; Sivori S; Carlomagno S; Moretta L; Moretta A
    Blood; 2013 Apr; 121(17):3396-401. PubMed ID: 23449637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-C matching and liver transplants: donor-recipient genotypes influence early outcome and CD8+KIR2D+ T-cells recuperation.
    López-Alvarez MR; Moya-Quiles MR; Minguela A; Gil J; Miras M; Campillo JA; Díaz-Alderete MA; García-Alonso AM; Sánchez-Bueno F; Vicario JL; Muro M; Alvarez-López MR
    Transplantation; 2009 Aug; 88(3 Suppl):S54-61. PubMed ID: 19667963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reassessing the impact of donor HLA-C genotype on long-term liver transplant survival.
    Tran TH; Middleton D; Döhler B; Scherer S; Meenagh A; Sleator C; Opelz G
    Am J Transplant; 2009 Jul; 9(7):1674-8. PubMed ID: 19392983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-C mismatching improves outcomes following lung transplantation.
    Hiho SJ; Levvey BJ; Diviney MB; Brooks AG; Holdsworth R; Snell GI; Westall GP; Sullivan LC
    HLA; 2024 Jun; 103(6):e15544. PubMed ID: 38924641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of the immunogenetic KIR and HLA systems on long-term renal transplant outcome.
    La Manna G; Corsini S; Iannelli S; Cappuccilli ML; Comai G; Iorio M; Todeschini P; Carretta E; Scolari MP; Bontadini A; Stefoni S
    Ann Transplant; 2013 Nov; 18():611-21. PubMed ID: 24220609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific combinations of donor and recipient KIR-HLA genotypes predict for large differences in outcome after cord blood transplantation.
    Sekine T; Marin D; Cao K; Li L; Mehta P; Shaim H; Sobieski C; Jones R; Oran B; Hosing C; Rondon G; Alsuliman A; Paust S; Andersson B; Popat U; Kebriaei P; Muftuoglu M; Basar R; Kondo K; Nieto Y; Shah N; Olson A; Alousi A; Liu E; Sarvaria A; Parmar S; Armstrong-James D; Imahashi N; Molldrem J; Champlin R; Shpall EJ; Rezvani K
    Blood; 2016 Jul; 128(2):297-312. PubMed ID: 27247137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Donor and recipient HLA/KIR genotypes do not predict liver transplantation outcome.
    Moroso V; van der Meer A; Tilanus HW; Kazemier G; van der Laan LJ; Metselaar HJ; Joosten I; Kwekkeboom J
    Transpl Int; 2011 Sep; 24(9):932-42. PubMed ID: 21672051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA-C-dependent prevention of leukemia relapse by donor activating KIR2DS1.
    Venstrom JM; Pittari G; Gooley TA; Chewning JH; Spellman S; Haagenson M; Gallagher MM; Malkki M; Petersdorf E; Dupont B; Hsu KC
    N Engl J Med; 2012 Aug; 367(9):805-16. PubMed ID: 22931314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Missing Self-Induced Microvascular Rejection of Kidney Allografts: A Population-Based Study.
    Callemeyn J; Senev A; Coemans M; Lerut E; Sprangers B; Kuypers D; Koenig A; Thaunat O; Emonds MP; Naesens M
    J Am Soc Nephrol; 2021 Aug; 32(8):2070-2082. PubMed ID: 34301794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haploidentical hematopoietic transplantation from KIR ligand-mismatched donors with activating KIRs reduces nonrelapse mortality.
    Mancusi A; Ruggeri L; Urbani E; Pierini A; Massei MS; Carotti A; Terenzi A; Falzetti F; Tosti A; Topini F; Bozza S; Romani L; Tognellini R; Stern M; Aversa F; Martelli MF; Velardi A
    Blood; 2015 May; 125(20):3173-82. PubMed ID: 25769621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uptake of CCR7 and acquisition of migratory properties by human KIR+ NK cells interacting with monocyte-derived DC or EBV cell lines: regulation by KIR/HLA-class I interaction.
    Marcenaro E; Cantoni C; Pesce S; Prato C; Pende D; Agaugué S; Moretta L; Moretta A
    Blood; 2009 Nov; 114(19):4108-16. PubMed ID: 19749090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Donor NK and T Cells in the Periphery of Lung Transplant Recipients Contain High Frequencies of Killer Cell Immunoglobulin-Like Receptor-Positive Subsets.
    Hitz AM; Bläsing KA; Wiegmann B; Bellmàs-Sanz R; Chichelnitskiy E; Wandrer F; Horn LM; Neudörfl C; Keil J; Beushausen K; Ius F; Sommer W; Avsar M; Kühn C; Tudorache I; Salman J; Siemeni T; Haverich A; Warnecke G; Falk CS; Kühne JF
    Front Immunol; 2021; 12():778885. PubMed ID: 34966390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Killer Cell Immunoglobulin-like Receptors (KIR) and Human Leucocyte Antigen C (HLA-C) Increase the Risk of Long-Term Chronic Liver Graft Rejection.
    Legaz I; Bolarín JM; Campillo JA; Moya-Quiles MR; Miras M; Muro M; Minguela A; Álvarez-López MR
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.